Home | Welcome to Contract Pharma   
Last Updated Sunday, May 19 2013
Print RSS Feed

Breaking News

Related Searches: Financial Reports •
Novartis

April 20, 2010
Revenues up 25% on big vaccine boost  Read More »
Financial Report: Lilly 1Q

April 19, 2010
Total revenue in the U.S. was up 6% to $3.0 billion and outside the U.S. increased 13% to $2.5 billion.   Read More »
Sandoz To Acquire Oriel

April 19, 2010
Sandoz has signed a definitive agreement to acquire Oriel Therapeutics, a privately held U.S. pharmaceutical company that develops respiratory products as generic alternatives to drugs for asthma and chronic obstructive pulmonary disease (COPD).  Read More »
PRA Establishes New Zealand Operations

April 19, 2010
PRA International has established operations in New Zealand, adding to the company’s Asia-Pacific operations.   Read More »
Patheon, Inc.

April 16, 2010
Mark Kontny, Ph.D. has joined Patheon, Inc. as president of Global Pharmaceutical Development Services (PDS) and as its chief scientific officer.  Read More »
Alexion's Soliris Approved in Japan

April 16, 2010
Alexion Pharmaceuticals, Inc. and Alexion Pharma International Sàrl received approval from Japan’s Ministry of Health, Labour and Welfare (MHLW) for the use of Soliris (eculizumab) as a treatment for patients in Japan with paroxysmal nocturnal hemog  Read More »
Roche

April 16, 2010
Group sales were up 9% in local currencies (lc).   Read More »
Novartis Restructures U.S. Ops

April 15, 2010
Novartis plans to restructure its U.S. operations. According to a company email, sent to employees by David Epstein, head of Novartis Pharmaceuticals, the restructuring is in response to a changing environment and is an effort to innovate the company&  Read More »
Charles River Shanghai Gets OECD Certification

April 15, 2010
Charles River Laboratories' Shanghai facility has received a Certificate of Good Laboratory Practice (GLP) compliance from the Organization for Economic Cooperation and Development (OECD).  Read More »
XOMA Earns $1M Takeda Milestone

April 15, 2010
XOMA Ltd. has received a $1 million milestone payment from Takeda Pharmaceutical Co. Ltd. for achieving a preclinical milestone under the companies' 2006 collaboration agreement.   Read More »
AVEO Earns $5M Biogen Milestone

April 14, 2010
AVEO Pharmaceuticals, Inc. has received a $5 million milestone payment from Biogen Idec International GmbH, a subsidiary of Biogen Idec, for the selection of the first humanized antibody development candidate from its ErbB3 program.  Read More »
FDA Approves J&J’s Pancreaze

April 14, 2010
Johnson & Johnson Pharmaceutical Research and Development (J&JPRD) received approval from the FDA for its NDA for Pancreaze (pancrelipase) delayed-release capsules for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis or ot  Read More »
Baxter’s Gammagard Shows Promise in AD

April 14, 2010
Baxter International and New York-Presbyterian Hospital/Weill Cornell Medical Center achieved positive results from an 18-month Phase II study of Gammagard Liquid and Gammagard S/D in mild-to-moderate Alzheimer’s disease.  Read More »
AMRI, Navigen Enter Research Pact

April 13, 2010
AMRI has entered a multi-year research collaboration with Navigen Pharmaceuticals focused on the development of new drug therapies.  Read More »
Patheon Adds Softgels at Cincinnati Site

April 13, 2010
Patheon is adding development and manufacturing softgel capability at its Cincinnati facility.   Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: